# Pharmaceutics International Inc - Inspection Records

Source: https://www.globalkeysolutions.net/companies/pharmaceutics-international-inc/89d3a795-b80a-4c2b-81fe-20abd08cf281

> Inspection records and compliance data for Pharmaceutics International Inc in Hunt Valley, Maryland. Access full analysis and detailed observations.

---

## Details

- Name: Pharmaceutics International Inc
- FEI Number: 1000513101
- City: Hunt Valley
- State: Maryland
- Country Name: United States
- Address Line 1: 10819 Gilroy Rd
- Zip Code: 21031
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Pharmaceutics International Inc - 2024-12-06](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/e2e84415-5d23-4319-901b-b9bbb7761500) — source: FDA, date: December 6, 2024
- [FDA Inspection 1251950 - Pharmaceutics International Inc - 2024-12-06](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/a92271af-599a-4b90-b2a0-68416a1bbecf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2024
- [FDA Inspection 1251950 - Pharmaceutics International Inc - 2024-12-06](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/a079c214-ff04-4388-aa69-9ebbc2076367) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2024
- [FDA Inspection 1251950 - Pharmaceutics International Inc - 2024-12-06](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/340bd068-8fd9-417e-a130-1c75f2a1fa1b) — source: FDA, date: December 6, 2024
- [FDA Inspection 1251950 - Pharmaceutics International Inc - 2024-12-06](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/5a6174e2-d4f9-44e3-bb42-bd5a2b343238) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2024
- [483 - Pharmaceutics International Inc - 2022-11-14](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/23d81323-3cfc-4b77-93b8-46e606c038b3) — source: FDA, date: November 14, 2022
- [EIR - Pharmaceutics International Inc - 2022-11-14](https://www.globalkeysolutions.net/records/eir/pharmaceutics-international-inc/2adaea6c-1bf7-4220-a187-496f2233d83b) — source: FDA, date: November 14, 2022
- [FDA Inspection 1194130 - Pharmaceutics International Inc - 2022-11-14](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/307b0cd0-fef1-4657-a0cd-1da6bcb2d852) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 14, 2022
- [483 - Pharmaceutics International Inc - 2021-09-29](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/eefcf4af-d937-4223-a88d-495e224ed1ec) — source: FDA, date: September 29, 2021
- [FDA Inspection 1155001 - Pharmaceutics International Inc - 2021-09-29](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/b5dd2b26-351a-4e95-97ae-bb05334780b9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2021
- [FDA Inspection 1155001 - Pharmaceutics International Inc - 2021-09-29](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/0980bc7f-4e1b-403b-b6ab-b5412b27a2b3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2021
- [483 - Pharmaceutics International Inc - 2020-10-30](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/0646990d-3723-4aaf-8660-3f93d931b33b) — source: FDA, date: October 30, 2020
- [483 - Pharmaceutics International Inc - 2020-07-10](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/643a5cd2-3c8d-4a2b-9a43-e72810bbabac) — source: FDA, date: July 10, 2020
- [FDA Inspection 1124614 - Pharmaceutics International Inc - 2020-07-10](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/47afea05-7c8f-483c-a1b1-c9bfeea374d2) — classification: No Action Indicated (NAI), source: FDA, date: July 10, 2020
- [483 - Pharmaceutics International Inc - 2018-11-09](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/9e005824-a2d7-45ef-897c-1a863e8ef353) — source: FDA, date: November 9, 2018
- [FDA Inspection 1071297 - Pharmaceutics International Inc - 2018-11-09](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/3d5a3b5e-a5c6-48b8-84a2-ebedc9d908ec) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2018
- [FDA Inspection 1071297 - Pharmaceutics International Inc - 2018-11-09](https://www.globalkeysolutions.net/records/fda_inspections/pharmaceutics-international-inc/2d6a7d4c-a3ec-4889-8f64-3ba0379f5b22) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2018
- [483 - Pharmaceutics International Inc - 2017-11-16](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/c0dca8aa-b540-4ad9-9302-54d60c3b66e2) — source: FDA, date: November 16, 2017
- [483 - Pharmaceutics International Inc - 2017-03-24](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/b07bb327-5fc1-42c1-84cd-82046c777127) — source: FDA, date: March 24, 2017
- [483 - Pharmaceutics International Inc - 2016-03-18](https://www.globalkeysolutions.net/records/483/pharmaceutics-international-inc/073299e1-26d0-4892-a7f1-668a441df51b) — source: FDA, date: March 18, 2016

## Related Companies

- [Takeda Pharmaceutical Company Limited](https://www.globalkeysolutions.net/companies/takeda-pharmaceutical-company-limited/185c125c-128f-47be-ab1b-e1d5324bcc21)
- [Centaur Pharmaceuticals Private Ltd.](https://www.globalkeysolutions.net/companies/centaur-pharmaceuticals-private-ltd/65d235da-0400-49d7-acff-38fe013fc5b4)
- [Seaway Pharma Inc.](https://www.globalkeysolutions.net/companies/seaway-pharma-inc/c01e07b5-654d-448f-aa7e-00617078e232)
- [Actavis Laboratories FL, Inc.](https://www.globalkeysolutions.net/companies/actavis-laboratories-fl-inc/6c959344-9e81-4c3c-9e6d-580e25151c7d)
- [Catalent Massachusetts, LLC](https://www.globalkeysolutions.net/companies/catalent-massachusetts-llc/26c89be4-8caa-4cb8-a699-31729cda5497)
- [GSK Vaccines GmbH](https://www.globalkeysolutions.net/companies/gsk-vaccines-gmbh/af5a9fae-fd5f-4aad-b88d-666e8cf72794)
- [Dr. Reddy's Laboratories Ltd.](https://www.globalkeysolutions.net/companies/dr-reddys-laboratories-ltd/5a4c4806-5444-4838-9cda-0b0da2f42221)
- [I3 PHARMACEUTICALS LLC](https://www.globalkeysolutions.net/companies/i3-pharmaceuticals-llc/020702e4-1539-47b8-87d9-725035cecbfe)
- [AAA Pharmaceutical, Inc.](https://www.globalkeysolutions.net/companies/aaa-pharmaceutical-inc/a4bd33c0-4805-416c-93f2-55e4116cc481)
- [HP Halden Pharma AS](https://www.globalkeysolutions.net/companies/hp-halden-pharma-as/2c8c6d51-da3a-476a-9abd-da411b527728)

## Related Officers

- [Vivin George](https://www.globalkeysolutions.net/people/vivin-george/0b0ee298-a577-4bee-b18e-42da0c3bb148)
- [Investigator](https://www.globalkeysolutions.net/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
- [James M. Swann](https://www.globalkeysolutions.net/people/james-m-swann/6100d7a8-14e7-493b-9e2b-500a92e3c870)
- [Consumer Safety Officer at FDA](https://www.globalkeysolutions.net/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
- [Pharmacy Intern/Certified Pharmacy Technician](https://www.globalkeysolutions.net/people/david-a-oluwo/209d60bd-27d8-487b-8249-1c6e44fcc317)
- [Young K. Chou](https://www.globalkeysolutions.net/people/young-k-chou/3f34cb70-7f30-453d-9099-885e1b168975)